Cr Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 09-12-2024
- Revenue 34.62%
(FY 2023)
- Profit 28.55%
(FY 2023)
- Ebitda 10282.29%
(FY 2023)
- Net Worth 22.28%
(FY 2023)
- Total Assets 24.44%
(FY 2023)
About Cr Meditech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M.
Pranay Shah, Chandrakant Shah, and Sejal Pranay serve as directors at the Company.
- CIN/LLPIN
U24232MH2008PTC180905
- Company No.
180905
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cr Meditech Private Limited offer?
Cr Meditech Private Limited offers a wide range of products and services, including Oxygen Mask, Flowmeter & Humidifier Bottle, Oxygen Mask, Medical Pillow, Cervical Collars, Anaesthetic Face Mask, Nasal Cannula, ECG Accessories, ECG Paper, Diagnostic Medical Imaging Equipment, Medical Electrodes.
Who are the key members and board of directors at Cr Meditech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranay Shah  | Director | 07-Apr-2008 | Current |
| Chandrakant Shah | Director | 07-Apr-2008 | Current |
| Sejal Pranay | Director | 07-Apr-2008 | Current |
Financial Performance of Cr Meditech.
Cr Meditech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.62% increase. The company also saw a substantial improvement in profitability, with a 28.55% increase in profit. The company's net worth Soared by an impressive increase of 22.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cr Meditech?
Unlock access to Cr Meditech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2022 | Idbi Bank Limited | ₹4.00 M | Open |
How Many Employees Work at Cr Meditech?
Unlock and access historical data on people associated with Cr Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cr Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cr Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.